Prelude Therapeutics raises another $50M to advance cancer therapies
August 28, 2020 at 10:42 AM EDT
The company has now raised $145 million since its launch four years ago.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|